Lanean...
Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure
Chronic heart failure (CHF) is the end-stage of many cardiovascular diseases and severely affects the patients’ lifespan. Inhibiting ventricular remodeling is thus a primary treatment target for CHF patients. Astragaloside IV (AS-IV) can improve cardiac function and protect myocardial cells. The stu...
Gorde:
| Argitaratua izan da: | Biosci Rep |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Portland Press Ltd.
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6048210/ https://ncbi.nlm.nih.gov/pubmed/29301869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20171036 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|